相关实验视频
Updated: May 27, 2025

08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
10.6K
疫苗失效模式决定了疫情期间疫苗接种活动对人口水平的影响
Da In Lee1,2, Anjalika Nande1, Thayer L Anderson1
1Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, USA.
Journal of the Royal Society, Interface
|February 18, 2025
概括
了解疫苗如何失效是控制传染病的关键. 这项研究表明,疫苗失效的方式显著影响流行病模型和疫苗接种策略,特别是在COVID-19等疾病中.
科学领域:
- 流行病学 流行病学
- 数学生物学 数学生物学
- 免疫学 免疫学 免疫学
背景情况:
- 疫苗对于控制传染病至关重要,但很少提供完美的保护.
- 疫苗有效性是人口的衡量标准,而模型需要个体级失效数据,从而产生模两可.
- 疫苗失效的确切方式 (例如,全部或无与泄漏) 往往没有量化.
研究的目的:
- 系统地调查不同疫苗失效模式对疫情控制的影响.
- 确定关于疫苗失败的假设如何影响数学模型预测.
- 评估失效模式对特定风险群体疫苗接种优先级的影响.
主要方法:
- 在各种疫苗失败场景下开发和分析传染病传播的数学模型.
- 与不同故障模式的模型预测进行比较 (全部或无,漏水,中间).
- 检查了模型结果对故障模式假设在不同流行病阶段的敏感性,包括COVID-19.
主要成果:
- 全效或无效与漏洞疫苗对人口水平的影响可能是相当大的,特别是在高的基本繁殖数 (R0),中间疫苗有效性以及疫苗只能减缓但不能阻止疫情爆发的情况下.
- 模型预测在流行病的特定阶段对疫苗失败模式假设非常敏感,例如在COVID-19大流行期间.
- 错误地将泄漏疫苗描述为全部或没有,或者反之亦然,可能会改变不同风险群体疫苗接种优先级的建议.
结论:
- 疫苗失效的模式是疫苗接种活动和流行病控制有效性的关键因素.
- 用于疫苗接种策略的数学模型应明确纳入关于疫苗失效模式的不确定性.
- 对疫苗失败的准确建模对于优化疫苗分配和公共卫生干预至关重要.
更多相关视频
08:52Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
8.1K
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.0K
相关概念视频
Vaccinations
43.8K
Overview
43.8K
Cross-reactivity
30.9K
Overview
30.9K
Steps in Outbreak Investigation
102
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
102
Pharmacovigilance
768
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
768
Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Infection
7.0K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.0K